Active Pharmaceutical Ingredients
Progestogen and Estrogen | |||
Product Name | Specification | Approved | CAS No. |
Progesterone | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Pregnenolone |
In-house |
Kosher | 145-13-1 |
Medroxyprogesterone Acetate | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrol Acetate | CP/EP/USP | DMF in process | 595-33-5 |
Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
Cyproterone Acetate | CP/EP | CEP/TGA/EU-GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | DMF/GMP/CEP | 797-63-7 |
Drospirenone | EP/USP | DMF | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP | DMF | 35380-71-3 |
Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
Ethinyl Estradiol | CP/EP/USP | DMF/GMP | 57-63-6 |
Estradiol Valerate | CP | DMF | 979-32-8 |
Tibolone | CP/EP | DMF | 5630-53-5 |
Dienogest | EP | DMF | 65928-58-7 |
Fulvestrant | In-house | Under R&D | 129453-61-8 |
Exemestane | EP/USP | Under R&D | 107868-30-4 |
Androgen | |||
Product Name | Specification | Approved | CAS No. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/DMF | 164656-23-9 |
Abiraterone Acetate | CP/USP | DMF/WC | 154229-18-2 |
Testosterone | CP/EP/USP | CEP/DMF/WC/FDA | 58-22-0 |
Testosterone Undecanoate | CP | DMF in process | 5949-44-0 |
Testosterone Cypionate | USP | Under R&D | 58-20-8 |
DHEA(Prasterone) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
Clascoterone | In-house | DMF in process | 19608-29-8 |
Cortical Hormone | |||
Product Name | Specification | Approved | CAS No. |
Budesonide | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonide | USP | DMF | 638-94-8 |
Eplerenone | EP | CEP/FDA | 107724-20-9 |
Methylprednisolone | CP/EP/USP | DMF/WC | 83-43-2 |
Methylprednisolone Hemisuccinate | CP/EP/USP | DMF/WC | 2921-57-5 |
Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
Fluticasone Furoate | In-house | DMF in process | 397864-44-7 |
Mometasone Furoate |
EP/USP |
DMF in process |
83919-23-7 141646-00-6 |
Others | |||
Product Name | Specification | Approved | CAS No. |
Oxcarbazepine | CP/EP/USP | CEP/DMF/GMP | 28721-07-5 |
Eslicarbazepine Acetate | In-house | DMF | 236395- 14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hydrochloride | USP | DMF | 175865-59-5 |
Oseltamivir Phosphate | CP/EP/USP | DMF | 204255- 11-8 |
Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
Nintedanib Esylate | In-house | DMF | 656247-18-6 |
Revefenacin | In-house | DMF | 864750-70-9 |
Mirabegron | In-house | DMF | 223673-61-8 |
Escitalopram Oxalate | EP/USP/CP | DMF in process | 219861-08-2 |
Cariprazine Hydrochloride | In-house | DMF | 1083076-69-0 |
Lasmiditan Succinate | In-house | DMF | 439239-92-6 |
Luliconazole | In-house | DMF | 187164-19-8 |
Apalutamide | In-house | DMF in process | 956104-40-8 |
Tadalafil | EP/USP/CP | Under R&D | 171596-29-5 |
Relugolix | In-house | DMF in process | 737789-87-6 |
Phloroglucinol | CP | DMF | 108-73-6 |
Ursodeoxycholic Acid | EP/USP/JP | Under R&D | 128-13-2 |
Omega-3-Acid Ethyl Ethers 90 |
EP/USP |
DMF in process |
—— |
Medium-Chain Triglycerides |
CP/USP/EP |
DMF in process |
—— |
Benzalkonium Chloride |
USP/EP/JP |
DMF |
8001-54-5 |
Progesterone has EP, USP, CP, JP, IP and KP specifications. CEP available, EU-GMP,FDA approved.
Finasteride has EP, USP, CP, IP, JP specifications. CEP available, FDA, PMDA and GMP approved.
Budesonide has USP, EP specifications. CEP, GMP and FDA approved.
Dutasteride has EP, USP, CP, IP, JP specification. CEP and FDA available.
Methylprednisolone has USP, EP, IP, JP and KP specifications. DMF and WC available.